October Pharma Co. (OCPH) Financials
Annual financial statement highlights for October Pharma Co. covering fiscal years 2014–2025. Figures are updated weekly from EGX filings via TradingView.
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Total assets | Total debt | Dividend per share |
|---|---|---|---|---|---|---|---|
| 2025 | — | — | — | — | — | — | — |
| 2024 | — | — | — | — | — | — | — |
| 2023 | — | — | — | — | — | — | — |
| 2022 | — | — | — | — | — | — | — |
| 2021 | — | — | — | — | — | — | — |
| 2020 | 544.13M | 88.26M | 3.6774 | 15.74M | 606.15M | 234.15M | 0.75 |
| 2019 | 523.72M | 33.83M | 1.4095 | 62.83M | 545.89M | 257.44M | 0.375 |
| 2018 | 400.84M | 18.32M | 0.7635 | -83.45M | 551.15M | 309.97M | 0.25 |
| 2017 | 350.16M | 45.26M | 1.9675 | -41.85M | 366.75M | 100.06M | 1.00 |
| 2016 | 288.11M | 35.13M | 1.4625 | 76.78M | 254.2M | 17.59M | 0.875 |
| 2014 | 202.07M | 7.84M | 0.3275 | 1.97M | 226.16M | 49.96M | 0.125 |
All figures in EGP. Source: company disclosures to the Egyptian Exchange via TradingView; updated weekly.